We are a life sciences company focused on personalized medicines.
Through PERSONALIZ3D™, we are developing and commercializing personalized peptide medicines using pharmaceutical 3D printing.
Our Leadership
We have experience across drug development, FDA approvals, commercialization, manufacturing, IP generation, capital markets, and public-company finance.
Our Strategic Assets
Our strategic assets include the development and FDA approval of ketamine, as well as an investment in cepharanthine.
Sign Up for Press Releases
Follow Us
OTCQB: PHRRF | CSE:PHRM
© COPYRIGHT 2026. PharmaTher Holdings Ltd. ALL RIGHTS RESERVED.
"The product candidates described on this website are investigational and have not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory authority. Safety and efficacy have not been established."